Bisoprolol

Bisoprolol

SCHEMBL3137111

CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.Cl

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1

The experimentally established mechanism targets of Bisoprolol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 known ✓ P08588 4/20 0.98
ADRB2 P07550 4/20 0.98
ADRB3 P13945 1/20 0.98
LMNA P02545 4/20 0.82
NFKB1 P19838 2/20 0.82
MEN1 O00255 1/20 0.82
THRB P10828 1/20 0.82
ALOX12 P18054 1/20 0.82
APEX1 P27695 1/20 0.82
MAPK1 P28482 1/20 0.82
KMT2A Q03164 1/20 0.82
MAPT P10636 1/20 0.62
PTGS1 P23219 1/20 0.61
SLC6A2 P23975 1/20 0.61
ADRA1A P35348 2/20 0.60
NR3C1 P04150 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2J2 P51589 1/20 0.60
PDE4D Q08499 1/20 0.60
BLM P54132 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bisoprolol SCHEMBL3137123 1.00 ADRB2 (0.98) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL20961 0.99 ADRB1 (1.00) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL20960 0.99 ADRB1 (1.00) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL6510329 0.99 ADRB1 (1.00) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL233810 0.99 ADRB1 (1.00) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL16821831 0.98 ADRB1 (0.98) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL16821829 0.98 ADRB1 (0.98) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL4269272 0.98 ADRB1 (0.98) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL14343724 0.93 ADRB2 (0.89) ADRB2ADRB1ADRB3LMNANFKB1
Bisoprolol SCHEMBL28880254 0.93 ADRB2 (0.89) ADRB2ADRB1ADRB3LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3357945-B1 ADHESIVE POLYMER AND MEDICAL ADHESIVE PATCH TEIKOKU SEIYAKU KK (JP) 2024-10-30 EP claimed
CN-108290990-B Adhesive polymer and medical adhesive patch 帝国制药株式会社 2022-02-01 CN claimed
US-11077069-B2 Adhesive polymer and medical adhesive patch TEIKOKU SEIYAKU CO., LTD (JP) 2021-08-03 US claimed
US-20180280315-A1 ADHESIVE POLYMER AND MEDICAL ADHESIVE PATCH TEIKOKU SEIYAKU CO., LTD. (JP) 2018-10-04 US claimed
EP-3357945-A1 ADHESIVE POLYMER AND MEDICAL ADHESIVE PATCH Teikoku Seiyaku Co., Ltd. (JP) 2018-08-08 EP claimed
CN-119837946-A Preparation method of spleen-strengthening and kidney-tonifying, heart-calming and nerve-soothing composition for activating blood circulation to dissipate blood stasis 刘宏伟 2025-04-18 CN disclosed
EP-3357945-B1 ADHESIVE POLYMER AND MEDICAL ADHESIVE PATCH TEIKOKU SEIYAKU KK (JP) 2024-10-30 EP disclosed
CN-112004520-B Modified release pharmaceutical powder compositions comprising a gastric raft formation system with triggered pulsatile drug release 特瑞斯制药公司 2024-08-23 CN disclosed
CN-108290990-B Adhesive polymer and medical adhesive patch 帝国制药株式会社 2022-02-01 CN disclosed
US-11077069-B2 Adhesive polymer and medical adhesive patch TEIKOKU SEIYAKU CO., LTD (JP) 2021-08-03 US disclosed
US-20180280315-A1 ADHESIVE POLYMER AND MEDICAL ADHESIVE PATCH TEIKOKU SEIYAKU CO., LTD. (JP) 2018-10-04 US disclosed
EP-3357945-A1 ADHESIVE POLYMER AND MEDICAL ADHESIVE PATCH Teikoku Seiyaku Co., Ltd. (JP) 2018-08-08 EP disclosed
CN-108290990-A Binding property polymer and medical adhesive adhesive preparation 帝国制药株式会社 2018-07-17 CN disclosed
US-20130006203-A1 ADHESIVE PATCH CONTAINING BISOPROLOL TOA EIYO LTD. (JP) 2013-01-03 US disclosed
EP-2540289-A1 ADHESIVE PATCH CONTAINING BISOPROLOL Nitto Denko Corporation (JP) 2013-01-02 EP disclosed
EP-2203192-A1 WOUND CARE FORMULATION Northern Health And Social Care Trust (GB) 2010-07-07 EP disclosed
WO-2009037500-A1 WOUND CARE FORMULATION NORTHERN HEALTH AND SOCIAL CARE TRUST (GB) 2009-03-26 WO disclosed